Reviewing Healthpeak Properties (DOC) and Its Peers

Healthpeak Properties (NYSE:DOC – Get Free Report) is one of 40 publicly-traded companies in the “Healthcare REITs” industry, but how does it contrast to its rivals? We will compare Healthpeak Properties to related companies based on the strength of its valuation, profitability, risk, analyst recommendations, institutional ownership, earnings and dividends.

Valuation and Earnings

This table compares Healthpeak Properties and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Healthpeak Properties $2.82 billion $71.35 million 35.66
Healthpeak Properties Competitors $1.27 billion $1.61 million -1.80

Healthpeak Properties has higher revenue and earnings than its rivals. Healthpeak Properties is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk and Volatility

Healthpeak Properties has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, Healthpeak Properties’ rivals have a beta of 0.85, suggesting that their average stock price is 15% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Healthpeak Properties and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Healthpeak Properties 0 14 4 0 2.22
Healthpeak Properties Competitors 430 2020 2011 86 2.39

Healthpeak Properties currently has a consensus target price of $21.60, suggesting a potential upside of 12.16%. As a group, “Healthcare REITs” companies have a potential upside of 14.70%. Given Healthpeak Properties’ rivals stronger consensus rating and higher probable upside, analysts plainly believe Healthpeak Properties has less favorable growth aspects than its rivals.

Insider and Institutional Ownership

93.6% of Healthpeak Properties shares are owned by institutional investors. Comparatively, 60.4% of shares of all “Healthcare REITs” companies are owned by institutional investors. 0.2% of Healthpeak Properties shares are owned by company insiders. Comparatively, 3.1% of shares of all “Healthcare REITs” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Dividends

Healthpeak Properties pays an annual dividend of $1.22 per share and has a dividend yield of 6.3%. Healthpeak Properties pays out 225.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Healthcare REITs” companies pay a dividend yield of 4.2% and pay out 121.0% of their earnings in the form of a dividend.

Profitability

This table compares Healthpeak Properties and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Healthpeak Properties 12.32% 4.04% 1.76%
Healthpeak Properties Competitors 26.19% 6.15% 3.48%

Summary

Healthpeak Properties rivals beat Healthpeak Properties on 9 of the 15 factors compared.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc. is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities. The company’s properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.